SB 786
Requires health benefit plans to provide orally administered anticancer medications on a basis no less favorable than intravenously administered anticancer medications
Sponsor:
LR Number:
4398S.02P
Last Action:
4/14/2010 - Hearing Conducted H Health Care Policy Committee
Journal Page:
Title:
SS SB 786
Calendar Position:
Effective Date:
August 28, 2010

Current Bill Summary

SS/SB 786 - Under this act, every health benefit plan that is issued in this state that provides coverage for cancer chemotherapy treatment must provide coverage for a prescribed, orally administered anticancer medication used to kill or slow the growth of cancerous cells on a basis no less favorable than intravenously administered or injected cancer medications that are covered under the health benefit plan. The act shall not apply to certain supplemental insurance policies such as specified disease policies, Medicare supplement policies, and similar products.

STEPHEN WITTE

Amendments